Page last updated: 2024-10-24

carbamazepine and Hepatitis E

carbamazepine has been researched along with Hepatitis E in 1 studies

Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.

Hepatitis E: Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brotherton, BJ1
Steinberg, I1
Johnson, JL1

Other Studies

1 other study available for carbamazepine and Hepatitis E

ArticleYear
Case 3: Fever, Vomiting, and Increased Sleepiness in a 4-year-old Girl.
    Pediatrics in review, 2015, Volume: 36, Issue:5

    Topics: Anticonvulsants; Carbamazepine; Chemical and Drug Induced Liver Injury; Child, Preschool; Diagnosis,

2015